| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cost of Revenue | $86K | — |
| Gross Profit | $1.4M | — |
| R&D Expense | $3.5M | -29.1% |
| SG&A Expense | $17.7M | +44.8% |
| Operating Income | -$22.6M | -31.2% |
| Income Tax | $0 | — |
| Net Income | -$23.7M | -36.7% |
| EPS (Basic) | -$0.90 | -34.3% |
| EPS (Diluted) | -$0.90 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.8M | +12.7% |
| Accounts Receivable | $1.5M | — |
| Current Assets | $26.7M | +19.4% |
| Total Assets | $26.9M | +20.2% |
| Current Liabilities | $4.6M | +178.7% |
| Long-term Debt | $24.9M | +398.0% |
| Total Liabilities | $29.5M | +344.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.1M | -27.0% |
| Financing Cash Flow | $20.7M | +316.5% |
| Stockholders' Equity |
| -$2.6M |
| -116.3% |